Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.
1. STOCK NEWS:
- Biogen (BIIB) gives up most of yesterday's gain after Samsung BioLogics denies report about takeover talks [more]
- Tesla (TSLA) recalls all 2017-2020 Model 3 vehicles to repair issue with rearview camera [more]
- Johnson & Johnson (JNJ) says COVID-19 vaccine booster demonstrates effectiveness against omicron in South African Phase 3b study [more]
- CDC says "avoid cruise travel, regardless of vaccination status" [more]
- Kroger (KR) board of directors approves $1B share repurchase authorization [more]
2. WALL STREET CALLS:
- Tractor Supply (TSCO) upgraded to Buy from Hold at Argus [more]
- Citic starts Zoom Video (ZM) with Buy on "clearly excessive" concerns [more]
- Curo Group (CURO) resumed with a Buy at Jefferies [more]
- Tesla (TSLA), Ford (F) and General Motors (GM) price targets raised at Citi [more]
- Biogen (BIIB) takeout report may bring "downside protection," says Canaccord [more]
3. AROUND THE WEB:
- FDA near allowing booster dose of Pfizer (PFE)-BioNTech (BNTX) vaccine for younger teens, NY Times says [more]
- Jana ramps up efforts to squash Zendesk's (ZEN) buyout of Momentive (MNTV), CNBC says [more]
- JetBlue (JBLU) slashes over 1,000 flights through mid-January, CNBC reports [more]
- Two-thirds of 2021 IPOs now trading below offer prices, WSJ reports [more]
- Energy Transfer (ET) ordered to pay $410M for nixing Williams (WMB) merger, Bloomberg reports [more]
4. MOVERS:
- Ocugen (OCGN) gains after its partner, Bharat Biotech, posted results from a Phase 2/3 trial conducted on COVAXIN in children [more]
- R.R. Donnelley (RRD) rises after announcing it received a non-binding proposal to be acquired at $11 per share [more]
- Teva (TEVA) slides after held liable by jury in New York opioid trial, says will appeal [more]
- Vector Group (VGR) lower after completing the spin-off of Douglas Elliman (DOUG) [more]
- Lucid Group (LCID) advances after Citi analyst Itay Michaeli resumed coverage of the stock with a Buy rating and $57 price target [more]
5. EARNINGS/GUIDANCE:
- Didi (DIDI) reported the equivalent of $6.7B in revenues for the three months ended Sept. 30 and posted a net loss equivalent to $4.8B for the third quarter [more]
- Royal Caribbean (RCL) provides update on omicron variant impact, says first half of 2022 load factors below historical levels, sees second half load factors within historical ranges [more]
- BeyondSpring (BYSI) reports Q3 losses, says "continued to move forward in developing plinabulin's potential" [more]
- Lotus Ventures (LTTSF) reports Q4 revenue down from last year [more]
- Bed Bath & Beyond (BBBY), Acuity Brands (AYI) among those set to report earnings next week [more]
INDEXES:
The Dow fell 90.55, or 0.25%, to 36,398.08, the Nasdaq lost 24.65, or 0.16%, to 15,741.56, and the S&P 500 declined 14.33, or 0.30%, to 4,778.73.